These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31831780)

  • 1. Caveolin-2 deficiency induces a rapid anti-tumor immune response prior to regression of implanted murine lung carcinoma tumors.
    Liu Y; Qi X; Li G; Sowa G
    Sci Rep; 2019 Dec; 9(1):18970. PubMed ID: 31831780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
    Liu M; Tong Z; Ding C; Luo F; Wu S; Wu C; Albeituni S; He L; Hu X; Tieri D; Rouchka EC; Hamada M; Takahashi S; Gibb AA; Kloecker G; Zhang HG; Bousamra M; Hill BG; Zhang X; Yan J
    J Clin Invest; 2020 Apr; 130(4):2081-2096. PubMed ID: 31945018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
    Li XY; Das I; Lepletier A; Addala V; Bald T; Stannard K; Barkauskas D; Liu J; Aguilera AR; Takeda K; Braun M; Nakamura K; Jacquelin S; Lane SW; Teng MW; Dougall WC; Smyth MJ
    J Clin Invest; 2018 Jun; 128(6):2613-2625. PubMed ID: 29757192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.
    Dammeijer F; Lievense LA; Kaijen-Lambers ME; van Nimwegen M; Bezemer K; Hegmans JP; van Hall T; Hendriks RW; Aerts JG
    Cancer Immunol Res; 2017 Jul; 5(7):535-546. PubMed ID: 28536100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.
    Rolny C; Mazzone M; Tugues S; Laoui D; Johansson I; Coulon C; Squadrito ML; Segura I; Li X; Knevels E; Costa S; Vinckier S; Dresselaer T; Åkerud P; De Mol M; Salomäki H; Phillipson M; Wyns S; Larsson E; Buysschaert I; Botling J; Himmelreich U; Van Ginderachter JA; De Palma M; Dewerchin M; Claesson-Welsh L; Carmeliet P
    Cancer Cell; 2011 Jan; 19(1):31-44. PubMed ID: 21215706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using macrophage activation to augment immunotherapy of established tumours.
    Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
    Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
    Ubil E; Caskey L; Holtzhausen A; Hunter D; Story C; Earp HS
    J Clin Invest; 2018 Jun; 128(6):2356-2369. PubMed ID: 29708510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
    Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
    Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8
    Murakami T; Hiroshima Y; Zhang Y; Zhao M; Kiyuna T; Hwang HK; Miyake K; Homma Y; Mori R; Matsuyama R; Chishima T; Ichikawa Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):634-639. PubMed ID: 28628234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
    Vuckovic S; Minnie SA; Smith D; Gartlan KH; Watkins TS; Markey KA; Mukhopadhyay P; Guillerey C; Kuns RD; Locke KR; Pritchard AL; Johansson PA; Varelias A; Zhang P; Huntington ND; Waddell N; Chesi M; Miles JJ; Smyth MJ; Hill GR
    J Clin Invest; 2019 Jan; 129(1):106-121. PubMed ID: 30300141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-Tumor M1 Macrophages.
    Park SM; Do-Thi VA; Lee JO; Lee H; Kim YS
    Mol Cells; 2020 May; 43(5):479-490. PubMed ID: 32326670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
    Front Immunol; 2019; 10():454. PubMed ID: 30967859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
    Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
    J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M1
    Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
    Kato Y; Tabata K; Kimura T; Yachie-Kinoshita A; Ozawa Y; Yamada K; Ito J; Tachino S; Hori Y; Matsuki M; Matsuoka Y; Ghosh S; Kitano H; Nomoto K; Matsui J; Funahashi Y
    PLoS One; 2019; 14(2):e0212513. PubMed ID: 30811474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.